SUN PHARMACEUTICAL IND LPanjang
Long
The stock is approximately 56.9% undervalued relative to its intrinsic value of 4,137.50, suggesting a significant buying opportunity at the current price of 1,783.
Based on technical analysis and market trends, a correction to around 1,600 to 1,400 could be an ideal buy zone, offering even greater upside potential for investors looking to enter at a discounted price. However, starting to accumulate shares at 1,783 could still provide a strong entry point for those with a long-term horizon
Based on technical analysis and market trends, a correction to around 1,600 to 1,400 could be an ideal buy zone, offering even greater upside potential for investors looking to enter at a discounted price. However, starting to accumulate shares at 1,783 could still provide a strong entry point for those with a long-term horizon
DO WHAT OTHERS DON"T KNOW AND DON'T DO WHAT OTHERS KNOW
DO WHAT OTHERS DON"T KNOW AND DON'T DO WHAT OTHERS KNOW
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.